Amisulpride: Clinical Trials

7 trials of Amisulpride, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown, 1 recruiting, 1 terminated. 7 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 3, Unknown 2, Recruiting 1, Terminated 1
Phase 21Completed 1

Follow Amisulpride: new trials by email Literature Review of Amisulpride trials Research Report on Amisulpride

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sequential Treatment Approaches for Treatment-Resistant Schizophrenia
[Phase 1] Clozapine, [Phase 1] Aripiprazole, [Phase 1] Amisulpride - Treatment-resistant Schizophrenia
Phase 3RecruitingShanghai Mental Health Center3002026-09-012026-11-05
Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients
Amisulpride Injection, Dexamethasone - Nausea and Vomiting, Postoperative
Phase 2 / Phase 3CompletedAcacia Pharma Ltd4532024-01-182025-06-25
A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV.
Amisulpride, Amisulpride Placebo - PONV
Phase 3UnknownQilu Pharmaceutical (Hainan) Co., Ltd.5162023-04-292023-04-21
Pharmacovigilance in Gerontopsychiatric Patients
Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression
Phase 3TerminatedHannover Medical School4072015-01-012018-02-28
US Phase III Study of APD421 in PONV
APD421- Amisulpride for IV injection, Placebo - PONV
Phase 3CompletedAcacia Pharma Ltd3642013-08-012019-02-12
Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis
Discontinuation antipsychotic treatment, Antipsychotic treatment - Psychosis Nos/Other
Phase 3UnknownFundación Pública Andaluza Progreso y Salud1042012-11-012014-12-05
Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation
Amisulpride, Moclobemide - Clozapine-induced Hypersalivation
Phase 3CompletedBeersheva Mental Health Center542008-11-012012-07-26

Conditions studied

Postoperative Nausea and Vomiting (3)  ·  Anxiety Disorders (1)  ·  Dementia (1)  ·  Depression (1)  ·  Psychophysiologic Disorders (1)  ·  Schizophrenia (1)  ·  Schizophrenia, Treatment-Resistant (1)

Sponsors

Acacia Pharma Ltd (2)  ·  Beersheva Mental Health Center (1)  ·  Fundación Pública Andaluza Progreso y Salud (1)  ·  Hannover Medical School (1)  ·  Qilu Pharmaceutical (Hainan) Co., Ltd. (1)  ·  Shanghai Mental Health Center (1)

Countries

Germany (2)  ·  United States (2)  ·  Canada (1)  ·  China (1)  ·  France (1)  ·  Israel (1)  ·  Spain (1)

Top investigators

Alexander Grinshpoon, MD (1)  ·  Anatoly Kreinin, MD, PhD (1)  ·  Chanoch Miodownik, MD (1)  ·  DengTang Liu (1)  ·  Diana Shestakova, MD (1)  ·  Helge Frieling, Prof., MD (1)  ·  Igor Libov (1)  ·  Kumar Belani, MD (1)  ·  Miguel Ruiz Veguilla, MD, PhD (1)  ·  Tong J Gan, MD (1)  ·  Vladimir Lerner, MD, PhD (1)

Results publications

PMID 20964499